Skip to main content

Novorapid & Levemir

Not a lot to report today, so thought I would tell you a bit about the insulins that I take. For those of you who are type I diabetics, this will be dull and you will probably know all about it, but for others, it may be good to see what is involved. Apologies if the picture below makes you feel uneasy, but it shows what an insulin pen looks like.

The needle attached is the smallest they do and is 5mm. The dial on the right is used to select the amount of insulin you want to inject. You then press the button and it clicks until the right dose is selected.

This insulin is called Novorapid. As the name suggests, this is a rapid action that starts working in 10 to 15 minutes. It peaks (as far as I can tell, although opinions on the net vary) in just over an hour and can be in the blood stream for 3-5 hours. I have also read that it can be gone in 2 hours, so am not sure about this figures. Novorapid is taken before meals and means that you can vary the times of your meal and if you want a meal high or low in carbohydrates you can change your dose accordingly. The technical name for this type of insulin is a bolus insulin.

The other insulin that I take is called Levemir. This is taken using a pen that looks the same as the Novorapid, except that it is green. It is an insulin analogue. This means that it is an insulin molecule with another molecule (glargine) attached. Although I can't find the exact mechanism at the moment, it appears the glargine molecule changes the solubility of the insulin. If the insulin doesn't dissolve in the blood stream, it can't be absorbed. The glargine molecule is gradually changed by the blood stream and dissolves leaving the insulin also to dissolve. This takes a number of hours and is gradual. In this way the insulin gets released over time. This is about 24 hours depending on the dose. Levemir is a basal insulin, i.e. it controls your baseline insulin. Lecture over!

Other events of note, was my successful cycle to and from work yesterday. It was hard work and my legs ached at the end, but it seemed to have a positive influence on my blood glucose and also made me feel good in myself! Didn't cycle today as it was throwing it down with rain and I am showing some people around the factory at 19:00 today so wanted to have time to have supper at home and come back.

The training course at work is still ongoing, therefore the buffet leftovers keep appearing. Today, they can't have been hungry as the picture of the left-overs shows:

As my levels were a bit high at lunchtime, I didn't eat any of it. The site secretary however sent me an email to say that she had saved me a couple of cans of Diet Coke as compensation. I was touched!

Finally, Abby wanted to come to work with me today. As it was raining she insisted on putting her wellies on with her dressing gown! Picture below:
Threw a bit of a tantrum when I said she couldn't come. What a confusing world it must be for a toddler, but I love her to bits!



Comments

Popular posts from this blog

The CCG Project!

In order to find out the situation around the country for Libre prescribing now that the national policy has been published, I have made the decision to contact many of them to find out their plans.  I have arbitrarily chosen to contact all English CCGs that in December 2018 prescribed Libre via Primary Care to less than 5% of their population (and one specific request from a group member).  I had hoped this would be a small list, but there are 135 CCGs on the list.  I may have bitten off more than I can chew, but I'm committed to doing this and feeding back.  It worked before and hopefully this level of scrutiny will bring similar results. Below is a screenshot of the base document I am sending to each of the CCGs - it has some fields that are merge fields, so don't worry about the brackets and codes in the document (I found a typo, which has now been corrected too) .  The major piece of work with respect to this is finding the right person to contact.  However, I have s

Abbott dX 2022 Barcelona - "Make it Count"

For the past four years I've been invited by Abbott to a conference bringing together people with diabetes from across Europe to discuss various topics.  The first year I was meant to attend, it was my 'man v horse' year (the horse won!), so was unable to attend and then the pandemic hit so two further dX's were held virtually.  I was fortunate to be asked to present at last year's session.  This year's event was back in-person and held in Barcelona, coinciding with the latter part of the ATTD conference.   At this point, I must make it very clear - Abbott invited me to the 2022 European Diabetes Exchange forum (dX), that took place in Barcelona.  I attended this two-day event to connect and interact with inspirational and influential people in the diabetes community.  Abbott paid for my ticket and accommodation. #InvitedbyAbbott.  This is formal and it needs to be - I have not been required to do anything by Abbott as a result of my attendance and I hope that m

July Update - CCGs Under Pressure!

The heat is unbearable in some parts, not only in the environment, but also hopefully the heat directed at the decision-makers in 'non-compliant' CCGs who are either refusing to accept that Libre is a revolutionary tool for many T1s or have agreed to fund, but then set crippling criteria. Latest Prescribing Data Progress in prescribing continues, with stabilisation in Scotland and a continuation of the steady rise in the other three countries of the UK.  The Wales May data should be out this week. As mentioned last month, the situation in Scotland is particularly promising and the excellent Edinburgh Centre for Endocrinology and the Scottish Health Technologies Group have published documents that should significantly help the Libre case.  These documents are based on the first six months of prescribing Libre. Healthcare Improvement Scotland Statement Flash Glucose Monitoring is associated with improved glycaemic control and quality of life in people with type 1 d